Aymée Alejandra Sarmiento-Zambrano
Research Subjects
Aymée Alejandra Sarmiento-Zambrano has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Angel Ernesto Gallegos-Goya1 shared publication
- Dennis Xavier Villa Ochoa
Hospital de Especialidades José Carrasco Arteaga
1 shared publication - Paola Azucena Sumba Tumbaco
Investigadora independiente
1 shared publication - Samuel Mateo Cusme-Chávez1 shared publication
Latest Publications
- Open Access
- 2 July 2026
- Published by Editorial Grupo de Asesoria Empresarial y Academica in Revista Científica Ciencia y Método
- Vol. 4 (3) , 249-264
Manejo quirúrgico y secreción hormonal en tumores neuroendocrinos gastroenteropancreáticos
The biological heterogeneity and hormonal hypersecretion of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) cause severe clinical syndromes and increase the risk of perioperative hemodynamic instability. To critically evaluate the impact of the hormonal secretion profile on the planning and success of the surgical approach to GEP-NETs. Methodology: A structured systematic review conducted in accordance with the PRISMA statement, covering 25 high-quality scientific articles published since 2020 in PubMed, SciELO, LILACS, and the scientific journal *Ciencia y Método*. R0 resection is the curative standard of care in localized stages. Hepatic cytoreduction (>90%) and somatostatin analogs prevent carcinoid crises and control symptoms, while laparoscopic enucleation is effective for preserving parenchyma in insulinomas. There is debate regarding the appropriateness of active surveillance versus surgery for incidental pancreatic lesions ≤2 cm due to high surgical morbidity, emphasizing the role of health education in optimizing postoperative adherence. Designing a surgical strategy carefully tailored to the tumor’s secretory function and histopathological profile is essential to maximize patient survival.
- 2 July 2026
- Published by Editorial Grupo de Asesoria Empresarial y Academica in Revista Científica Ciencia y Método
- Vol. 4 (3) , 249-264
Open AccessManejo quirúrgico y secreción hormonal en tumores neuroendocrinos gastroenteropancreáticos
The biological heterogeneity and hormonal hypersecretion of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) cause severe clinical syndromes and increase the risk of perioperative hemodynamic instability. To critically evaluate the impact of the hormonal secretion profile on the planning and success of the surgical approach to GEP-NETs. Methodology: A structured systematic review conducted in accordance with the PRISMA statement, covering 25 high-quality scientific articles published since 2020 in PubMed, SciELO, LILACS, and the scientific journal *Ciencia y Método*. R0 resection is the curative standard of care in localized stages. Hepatic cytoreduction (>90%) and somatostatin analogs prevent carcinoid crises and control symptoms, while laparoscopic enucleation is effective for preserving parenchyma in insulinomas. There is debate regarding the appropriateness of active surveillance versus surgery for incidental pancreatic lesions ≤2 cm due to high surgical morbidity, emphasizing the role of health education in optimizing postoperative adherence. Designing a surgical strategy carefully tailored to the tumor’s secretory function and histopathological profile is essential to maximize patient survival.